Armando Anido
2020
In 2020, Armando Anido earned a total compensation of $1.5M as Chairman of the Board and CEO at Zynerba Pharmaceuticals, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $263,369 |
|---|---|
| Option Awards | $580,674 |
| Salary | $585,265 |
| Other | $53,441 |
| Total | $1,482,749 |
Anido received $585.3K in salary, accounting for 39% of the total pay in 2020.
Anido also received $263.4K in non-equity incentive plan, $580.7K in option awards and $53.4K in other compensation.
Rankings
In 2020, Armando Anido's compensation ranked 6,872nd out of 13,090 executives tracked by ExecPay. In other words, Anido earned more than 47.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,872 out of 13,090 | 48th |
Division Manufacturing | 2,867 out of 5,621 | 49th |
Major group Chemicals And Allied Products | 1,157 out of 2,254 | 49th |
Industry group Drugs | 995 out of 1,954 | 49th |
Industry Pharmaceutical Preparations | 740 out of 1,459 | 49th |
Source: SEC filing on April 21, 2021.
Anido's colleagues
We found two more compensation records of executives who worked with Armando Anido at Zynerba Pharmaceuticals in 2020.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019